3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
9
Recruiting
4
Terminated
2
Unknown
1
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
26
Lymphoma
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Leukemia
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
10
Central Nervous System Neoplasms
8
Lymphoma, Follicular
6
Hodgkin Disease
6
Sarcoma
5
Retinoblastoma
5
Lymphoma, T-Cell, Peripheral
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Immunoblastic Lymphadenopathy
4
Wilms Tumor
3
Oligodendroglioma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Kidney Neoplasms
3
Burkitt Lymphoma
3
Astrocytoma
3
Recurrence
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Multiple Myeloma
2
Leukemia, T-Cell
2
Leukemia, Biphenotypic, Acute
2
Enteropathy-Associated T-Cell Lymphoma
2
Interventions
Cyclophosphamide
5
fludarabine
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Gemcitabine
3
fludarabine phosphate
2
endostar protein
2
Melphalan
2
Etoposide
2
Doxorubicin
2
Cisplatin
2
Alemtuzumab
2
thymoglobulin
1
spartalizumab
1
selinexor
1
pembrolizumab
1
Vindesine
1
Vincristine
1
Sensitivity and Specificity
1
Rituximab
1
Prednisone
1
Prednisolone
1
Methylprednisolone
1
Interleukin-2
1
Flavin-Adenine Dinucleotide
1
Epirubicin
1
Endostatins
1
Drug Therapy
1
Dexamethasone
1
Cytarabine
1
Clinical Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, T-Cell
×
Vincristine
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled